FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency’s decisions from public scrutiny.
CSPI's Strategic Plan 2025-2030 reinforces and expands our commitment to evidence-based and community-informed nutrition, food safety, and health policies.
34 years after banning Red 3 from cosmetics and topical drugs, the FDA has finally moved to remove the carcinogenic additive from food, drugs, and supplements.
